Patrick Johnson, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    AstraZeneca
    Topic:
    CLL
    Date added:
    08/04/2022
    Date updated:
    08/04/2022
    Relationship end date:
    11/30/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Seagen
    Topic:
    Hodgkin lymphoma
    Date added:
    08/04/2022
    Date updated:
    08/04/2022
    Relationship end date:
    08/31/2022
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    ADC Therapeutics
    Topic:
    Diffuse large B-cell lymphoma
    Date added:
    08/04/2022
    Date updated:
    08/04/2022
    Relationship end date:
    08/31/2022
Return to 2022 Cellular Therapy Conference – Translating recent evidence on cellular therapy to real world management of malignancies